Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • API Reference

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Mercury NZ (MCY) / FY25

Result released19 August 2025·Annolyse analysis published21 April 2026

FY25 EBITDAF fell 10.4% to $786m, missing $820m HY25 guidance

Dry conditions cut renewable generation 10% just as capex jumped 47.6% and net debt/EBITDAF stepped up from 2.2x to 2.8x.

Energy & Utilities / Integrated gentailer

MCY revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY25 was $3.5b, versus $3.4b in FY24.

MCY EBITDAF margin

EBITDAF margin across covered periods.

↗
Loading chart...
  • FY23 MCY FY: Unprecedented high ebitda margin. 30.8%; 4-period range 22.5% to 26.6%. EBITDA margin: 30.8%, unprecedented high; 4-period mean 24.3%, range 22.5%-26.6%.
  • FY25 MCY FY: Outside range low ebitda margin. 22.5%; 4-period range 22.6% to 30.8%. EBITDA margin: 22.5%, below normal range; 4-period mean 26.4%, range 22.6%-30.8%.
  • HY23 MCY HY: Unprecedented high ebitda margin. 34.7%; 4-period range 23.8% to 32.3%. EBITDA margin: 34.7%, unprecedented high; 4-period mean 27.7%, range 23.8%-32.3%.
  • HY25 MCY HY: Unprecedented low ebitda margin. 23.8%; 4-period range 27% to 34.7%. EBITDA margin: 23.8%, unprecedented low; 4-period mean 30.4%, range 27.0%-34.7%.
EBITDA margin: 23.8%, unprecedented low; 4-period mean 30.4%, range 27.0%-34.7%.

MCY operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY25 was $483m, versus $612m in FY24.

MCY working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
HY25 was -$17m, versus $539m in HY24.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 20 July 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$9.5b

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

108.17x

i

Recent market cap compared with trailing earnings.

EPS

0.06

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

13.03x

i

Enterprise value compared with recent EBITDA.

P/FCF

Not available

i

Not available for this company right now.

P/B

1.98x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

3.7%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
19 August 2025
Published
21 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

FY25 vs FY24

Revenue

$3.5b

+2.2% ↑ vs $3.4b

Net profit after tax

$1m

-99.7% ↓ vs $290m

Net cash inflow from operating activities

$483m

-21.1% ↓ vs $612m

Full-year dividend per share

24.0c

+3.0% ↑ vs 23.3c

EBITDAF

$786m

-10.4% ↓ vs $877m

Profit before tax

$1m

-99.8% ↓ vs $415m

Cash and cash equivalents

$86m

+95.5% ↑ vs $44m

Total assets

$10b

+1.7% ↑ vs $9.8b

Analysis ofMCY FY25·Result released19 August 2025·Annolyse analysis published21 April 2026

What changed

Mercury delivered FY25 EBITDAF of $786m, down 10.4% from $877m and approximately 4% below the $820m guidance the company reaffirmed at HY25

Revenue rose 2.2% to $3.5b on retail pricing and customer growth, but lower hydro generation cut total renewable output 10% to 7.9 TWh, which drove the underlying earnings shortfall.

Operating cash flow fell 21.1% to $483m, and cash conversion (OCF/EBITDAF) deteriorated to 61.5% from 69.8%. Capex surged 47.6% to $437m, lifting capex intensity to 12.5% of revenue from 8.6%. Gross borrowings rose 17.4% to $2.3b and net debt/EBITDAF stepped from 2.16x to 2.79x.

Reported PBT and NPAT both collapsed to about $1m from $415m and $290m. The growth percentages on those lines are not analytically meaningful at near‑negative‑100%, so EBITDAF is the cleaner read on operating performance.

What matters

Generation shortfall drove EBITDAF below guidance

The release attributes the result to dry hydrology and spot‑price spikes during peak demand. The 10% drop in renewable generation is closely matched by the 10.4% EBITDAF decline, which means the miss looks hydrology‑driven rather than structural, but it has consumed a guidance the company reaffirmed only six months earlier at HY25 EBITDAF of $418m.

Capex and leverage are accelerating together. Capex intensity rose 390bps to 12.5% of revenue while EBITDAF shrank, so net debt/EBITDAF has moved from a comfortable 2.16x to 2.79x with the build cycle still in front. Mercury cites a wind‑build pipeline and long‑term agreements with Fonterra and Visy as the rationale, but the leverage ratio is being squeezed from both numerator and denominator simultaneously.

Reported NPAT and PBT are not the operating read. The effective tax rate moved from 30.1% to 0.0%, and the near‑complete collapse of PBT and NPAT against only a 10% EBITDAF decline implies material non‑cash items between EBITDAF and reported profit. The supplied disclosure does not name the driver, so the composition of the gap remains unresolved.

Expectations

Mercury entered the second half with FY25 EBITDAF guidance of $820m reaffirmed; the implied second‑half EBITDAF of $368m (versus $418m in HY25) was insufficient to meet that bar

The board has guided FY26 ordinary dividend of 25cps (versus 24.0cps declared for FY25), and the release references an "indicative FY30 EBITDAF aspiration" without a quantified path.

The supplied excerpts do not contain FY26 EBITDAF guidance. Without it, the read on whether $786m represents a hydrology low or a new base in a heavier‑capex configuration cannot be settled from this filing alone. The prior FY24 comparable also incorporated the completed Trustpower retail integration, so the year‑on‑year step is not a perfectly clean like‑for‑like.

Quality of result

The EBITDAF decline is operational and tied to disclosed hydrology, not an accounting or timing effect; the economic quality of that line is broadly intact even though the level is lower

The total ordinary dividend rose to 24.0cps from 23.3cps and is guided to 25cps for FY26, but FY24's distribution already represented 111.8% of NPAT, so dividend cover is increasingly a build‑cycle funding decision rather than a current‑earnings outcome.

Working capital released $105m via a $122m drop in trade debtors (receivable days fell to 40.3 from 54.2), yet operating cash flow still declined 21.1%. That tells you the underlying cash quality of EBITDAF is weaker than the headline working‑capital tailwind suggests, and the receivables normalisation is unlikely to repeat at the same scale. Company‑defined free cash flow of $345m (down from $470m) sits well below the $437m of total capex, and the funding gap is being closed by the $338m lift in gross borrowings — which is what the leverage ratio is now reflecting.

Unresolved

Open questions

What specific items drove PBT and NPAT to approximately $1m given EBITDAF of $786m — are these fair‑value movements on the derivative hedge book, impairments, or other non‑cash charges?
Why did the effective tax rate fall to 0.0% from 30.1%, and is that a function of pre‑tax mix this year or a recurring feature?
What is FY26 EBITDAF guidance, and on a normal‑hydrology assumption does the $820m FY25 reference point remain the right anchor?
How much of the $437m capex is contractually committed versus discretionary, and where does net debt/EBITDAF peak through the build cycle?
What share of the Fonterra and Visy long‑term agreements is reflected in FY25 revenue versus future periods?

This briefing cannot assess the composition of the gap between EBITDAF and reported NPAT without specific disclosure of the fair‑value, derivative, or other non‑cash items sitting below the EBITDAF line.

Chat

Ask about MCY FY25

Ask follow-up questions about Mercury NZ's FY25 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about MCY FY25

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Mercury NZ's FY25 result.

What specific items drove PBT and NPAT to approximately $1m given EBITDAF of $786m — are these fair‑value movements on the derivative hedge book, impairments, or other non‑cash charges?Why does "Generation shortfall drove EBITDAF below guidance" matter?How strong was the cash and earnings quality in FY25?What should I watch next for MCY after FY25?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

FY2025 Full year results presentation

FY25 / results presentation↗

FY2025 Integrated report and financial statements

FY25 / financial report↗

News Release - Major renewable build advanced despite 10% earnings dip

FY25 / media release↗

NZX Results announcement

FY25 / results announcement↗

Prior comparable period

FY2024 Full year results presentation

FY24 / results presentation↗

FY2024 Integrated report and financial statements

FY24 / financial report↗

News release - Mercury results unlock up to $1 billion of investment

FY24 / media release↗

NZX Results announcement

FY24 / results announcement↗

Interim context

HY2025 Financial Results Announcement

HY25 / results announcement↗

HY2025 Interim Report including unaudited financial statements

HY25 / financial report↗

HY2025 News Release

HY25 / media release↗

HY2025 Results Presentation

HY25 / results presentation↗

Release context

FY25 Annual results presentation details

FY25 / commentary↗

News Release Investor Day

FY25 / commentary↗

Interim results presentation details

HY25 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 61.5% of EBITDA to operating cash flow, -8.3pp versus the prior comparable period.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 0.1pp, with a distortion flag in the result.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 2.79x, +0.63x versus the prior comparable period.

→

ROE and capital efficiency

ROE was 0.0%, -6.0pp versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when MCY publishes next

Get the next Mercury NZ briefing and related NZX reporting-season updates by email.